MAY 28, 2014 03:00 PM PDT

Vitamin D Testing in the Clinical Laboratory: The Status in 2014

Speakers
  • Professor of Endocrine Bone Research Laboratory, Univ of South Australia
    Biography
      Professor Howard Morris is Professor of Medical Sciences at the University of South Australia and a Chief Medical Scientist in Chemical Pathology at SA Pathology, Adelaide, South Australia. He is currently Vice-President of the International Federation of Clinical Chemistry and Laboratory Medicine (IFCC) and Chair of the IFCC-International Osteoporosis Foundation Working Group on Standardization of Bone Marker Assays. He has over 30 years experience in Clinical Biochemistry largely managing the Endocrinology laboratory of a large public pathology service. Between 2003 and 2009 he was the Director of the Hanson Institute in Adelaide, the major medical research institute in South Australia. His research investigates the pathophysiology of osteoporosis and the effects of hormones including vitamin D and dietary calcium. He was the Louis Avioli Memorial Lecturer at the 2009 Annual Scientific Meeting of the American Society for Bone and Mineral Research. He is also Chair of the South Australian Department of Health Working Party on Osteoporosis and Fracture Prevention.

    Abstract:

    Interest in vitamin D status remains high amongst the public and medical profession alike stimulating a surge in requests for clinical laboratories to measure patient serum 25-hydroxyvitamin D levels. It is stimulated by reports that a low vitamin D status is common and is associated with an increased incidence of a variety of diseases. Questions facing the clinical laboratory providing this service include: How reliable are the various serum 25-hydroxyvitamin D assays that are available to the clinical laboratory and which patient groups benefit most from this test? In the past confidence in the quality of serum 25-hydroxyvitamin D assays has been questioned. An internationally accepted reference measurement procedure and reference standards for serum 25-hydroxyvitamin D assays are now available. Restandardization of routine automated assays has been implemented for a number of assays demonstrating considerable improvement in the accuracy of these assays for most patient groups. However recent data suggest that for some patient groups inaccuracy is still a significant clinical problem. The highest levels of evidence indicate that the elderly with a low vitamin D status benefit from vitamin D and dietary calcium supplementation to reduce risks of premature mortality, falls and fractures. There is no agreement that screening for vitamin D deficiency in the general population is cost effective. However there is agreement that a variety of patients groups can benefit by correcting their vitamin D deficiency. Interpretation of serum 25-hydroxyvitamin D levels remains highly controversial although considerable advances have been made elucidating the physiology of vitamin D metabolite homeostasis.


    Show Resources
    You May Also Like
    MAY 22, 2018 08:00 AM PDT
    C.E. CREDITS
    MAY 22, 2018 08:00 AM PDT
    DATE: May 22, 2018TIME: 08:00AM PDT The nuclear receptors pregnane X receptor (PXR) and constitutive androstane receptor (CAR) are closely related transcription factors that...
    MAY 24, 2018 09:30 AM PDT
    C.E. CREDITS
    MAY 24, 2018 09:30 AM PDT
    DATE: May 24, 2018 TIME: 9:30PM PDT The current gold standard in in vitro pre-clinical cancer treatment screening remain cell lines,...
    MAY 03, 2018 11:00 AM PDT
    MAY 03, 2018 11:00 AM PDT
    DATE: May 3, 2018TIME: 11:00AM PDT, 2:00PM EDTWhile stress is one of the leading causes of neuropsychiatric disorders, the molecular underpinnings of how stress induces alterations in b...
    JUN 26, 2018 06:00 AM PDT
    C.E. CREDITS
    JUN 26, 2018 06:00 AM PDT
    Date: June 26, 2018Time: 6:00 a.m. PDT, 9:00 a.m. EDT, 1500 CEST Today’s hematology analyzers employ various methods for enumerating platelets. These methods include: e...
    JUN 20, 2018 10:00 AM EDT
    C.E. CREDITS
    JUN 20, 2018 10:00 AM EDT
    DATE: June 20, 2018TIME: 07:00AM PDT, 10:00AM EDTIntroducing GE’s New Lyo-StableTM service. Sepsis is one of the top challenges facing hospitals in terms of clinical outcomes...
    APR 27, 2018 10:00 AM PDT
    C.E. CREDITS
    APR 27, 2018 10:00 AM PDT
    DATE: April 27, 2018TIME: 10:00am PST, 1:00pm ESTGlioblastoma (GBM) and Medulloblastoma (MB) are the most common adult and paediatric brain tumours, both of which can have devastating c...
    Loading Comments...